COVID-19 Resources for North Carolina Life Science Companies and Researchers
Given the role North Carolina's life science community may play in response to the COVID-19 virus, and the effect the outbreak may have on business operations, this page compiles resources and news relevant to local life science companies and researchers.
Last update: April 2, 2020
Coronavirus Treatment Acceleration Program (CTAP)
FDA has created a special emergency program for possible therapies, the Coronavirus Treatment Acceleration Program (CTAP). It uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful.
NCBiotech Flash Grant
Deadline: April 22, 2020, 12:00 p.m.
NCBiotech’s Flash Grant program aims to identify and energize the most creative ideas that exhibit early indications of commercial potential. The current cycle is open only to the following topics:
- Global Coronavirus disease (COVID-19) outbreak - vaccine development, diagnosis, and COVID-19 specific therapies
- Precision health
- Digital and data-driven life science technologies (see page 2 for details)
2019 Novel Coronavirus Medical Countermeasure Partnership Opportunities available through BARDA
BARDA is working with its partners to identify promising medical countermeasures and technologies to combat the 2019 novel coronavirus. There are three ways your company or organization can partner with BARDA to fight the ongoing novel coronavirus outbreak.
Tune into a virtual info session hosted by First Flight Venture Center on March 25, 2020 at 12:00 p.m. Register Here
NSF SBIR/STTR Phase I Proposals Addressing COVID-19
The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis. Areas of research that might be considered include, but are not limited to: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations.
COVID-19 Therapeutics Accelerator
Announced March 10, 2020; more information forthcoming.
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments.
Centers for Disease Control COVID-19 Broad Agency Announcement
This BAA is open and in effect for 14 days from the date of issuance (March 11, 2020 through March 25, 2020).
- Surveillance, natural history and household transmission of SARS CoV-2
- Diagnostics development and novel technology development and evaluation to improve diagnostic testing capabilities for COVID-19 detection
- Immune response and transmission dynamics for SARS CoV-2
- Host infection dynamics for SARS CoV-2
- Prospective Cohorts to Assess COVID-19 and Other Respiratory Diseases
NIH Notices of Special Interest
The NIH is issuing Notices of Special Interest (NOSI), targeted opportunities specific to COVID-19 intended to provide funds for NIH grantees applying to expand the scope of their active grant. See NIH guidance for applicants and recipients, as well as these funding opportunities.
NSF Letter on the COVID-19
NSF encourages the research community to respond to this challenge through existing funding opportunities. In addition, they NSF invites researchers to use the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency with regard to availability of or access to data, facilities or specialized equipment as well as quick-response research on natural or anthropogenic disasters and similar unanticipated events.
See other NSF Guidance here.
Medical CBRN Defense Consortium (MCDC) Other Transaction Agreement (OTA) Request for Information (RFI) – CoV Pandemic Response
The purpose of this special notice is to obtain information via White Papers from both MCDC members and other interested industry/academia partners in response to the novel Coronavirus (2019-nCoV) pandemic in the United States (U.S.). Entities are encouraged to provide innovative products and technologies that in the short term (1-6 months), can be rapidly deployed to combat the current pandemic. Long-term solutions (6 months and beyond) are not requested at this time. For this request, submission is open to all entities of the US Defense Industrial Base, not just MCDC members. It is anticipated this Special Pandemic Response RFI will remain open through May 31, 2020, and may be extended if needed.
Medical Technology Enterprise Consortium (MTEC)
This solicitation, issued by the MTEC Consortium Manager (CM), Advanced Technology International (ATI), represents a Request for Project Proposals (RPP) for MTEC support of the USAMRDC’s Military Infectious Diseases Research Program (MIDRP). Military relevance is a critical component of Enhanced White Paper submission. Strategic and tactical oversight for the award(s) supported by this RPP will be provided by the MIDRP.
FOCUS AREA: Therapeutic(s) that can treat COVID-19. Treatments with potential application to the prevention of COVID-19 infection are desired. Therapeutics that can be administered in a non-hospital environment are desired.
American Heart Association Rapid Response Grant: COVID-19 and its Cardiovascular Impact
American Heart Association (AHA) invites cardiovascular-focused applications that will contribute to understanding the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management (including critical care management) and social behaviors which can lead to dissemination, containment, and complications of COVID-19.
NIST Manufacturing USA National Emergency Assistance Program
NIST invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic.
C3.ai Digital Transformation Institute: MItigation of COVID-19 and Future Pandemics
In the context of the Worldwide COVID-19 Pandemic, the C3.ai DTI is soliciting Research Award proposals that catalyze cooperative research activities and advances in machine learning and other AI subdisciplines, analytics, statistical analysis, and advanced computing research aimed at (1) the current acute challenges with COVID-19 and (2) the methods for containing and addressing pandemics more generally for longer-term preparedness, including for future pathogens and SARS-like viruses.
BIO Coronavirus Hub
The BIO Coronavirus Hub is the primary life scicence-focused resource to connect companies that have relevant supplies, capacities, and resources to share, with those companies, researchers, or healthcare providers that need them. The new hub will enable users to post requests for urgently needed items, as well as to post the availability of supplies and capacity. Connections for medical supplies will be facilitated in partnership with Healthcare Ready to ensure an organized and optimized allocation of items in need, and thus will not be publicly available or searchable.
Additional calls to action and resources are below.
NC DHHS Calls for Health Care Volunteers
The North Carolina Department of Health and Human Services (NC DHHS) is calling for health care volunteers to assist with the COVID-19 response. They are seeking volunteers in the following areas: Clinical (physicians, advanced care providers, nurses, EMS); Clinical Support (pharmacy, imaging and respiratory care); Non-clinical Support (facility maintenance, safety, administrative). The full letter is available here.
Critical Supply Production Database
IES/NCMEP is building a database of companies with certain capabilities during this critical time. There are over 20 critical supplies needed to respond to COVID-19. If your company currently does or can quickly begin production, please fill out the information below. NCMEP will share this information with federal and state stakeholders such as the US Department of Commerce and NCDPS Emergency Management agency to help meet these needs. Furthermore, your secured information provides us with crucial analytical data to dynamically generate topics, related companies, and resources.
North Carolina Business Relief Resources (EDPNC)
Low-interest lending options, layoff aversion resources, and other small business relief resources.
NC Covid-19 Rapid Recovery Loan Program (Golden LEAF Foundation)
In response to the unique economic challenges of COVID-19, a consortium of public, private, and nonprofit partners have come together and launched an innovative recovery-lending program to help support entrepreneurs like you and stabilize North Carolina’s small business sector.
CARES Act (Federal Coronavirus Aid Package)
The Coronavirus Aid, Relief, and Economic Security (CARES) Act provides the opportunity for many businesses to get up to a $10,000 advance on an Economic Injury Disaster Loan, and allows employers to delay the payment of their 2020 payroll taxes until 2021 or 2022. Additionally, the legislation reinstated tax provisions allowing businesses to carry back losses from 2018, 2019, and 2020 to the previous 5 years, which gives businesses immediate access to tax refunds.
Coronavirus (COVID-19): Small Business Guidance & Loan Resources (SBA)
Small business owners in all U.S. states and territories are currently eligible to apply for a low-interest Economic Injury Disaster loan due to Coronavirus (COVID-19). Furthermore If a small business has an urgent need for cash while waiting for decision and disbursement on Economic Injury Disaster Loan, they may qualify for an SBA Express Disaster Bridge Loan.
The SBTDC has prepared a presentation about applying for an SBA Economic Injury Disaster Loan. View this here. The SBTDC is also able to assist with submitting the loan application.
SBA Payroll Protection Program
Through the SBA, businesses of under 500 employees per location are eligible to receive up to 8 weeks of cash flow assistance through federally guaranteed loans. Importantly, if the employer receiving the loan maintains payroll and does not terminate employees, the portion of the loan used to meet payroll, mortgage obligations, rent, and utilities will be completely forgiven.
Coronavirus Tax Relief (IRS)
The Treasury Department and the Internal Revenue Service are providing special tax filing and payment relief to individuals and businesses in response to the COVID-19 Outbreak. The filing deadline for tax returns has been extended from April 15 to July 15, 2020.
The N.C. Department of Revenue (NCDOR) recently announced that they will extend the April 15 tax filing deadline to July 15 for individual, corporate, and franchise taxes to mirror the announced deadline change from the Internal Revenue Service. Read more.
Facebook Small Business Grants Program
Facebook is offering $100M in cash grants to help cover workforce, rent and operational costs to 30,000 eligible small businesses in over 30 countries where they operate.
JPMorgan Chase Philanthropic Investment
JPMorgan Chase announced a $50 million global philanthropic commitment to address the immediate public health and long-term economic challenges from the COVID-19 global pandemic. $8M from this commitment is for small business assistance, specifically to aid Black, Hispanic and Asian Pacific Islander-owned businesses.
Updates from the FDA (FDA)
Interim Guidance for Businesses and Employers (CDC)
This interim guidance is based on what is currently known about the coronavirus disease 2019 (COVID-19). The Centers for Disease Control and Prevention (CDC) will update this interim guidance as needed and as additional information becomes available.
Also see the CDC's Business Pandemic Influenza Planning Checklist and Pandemic Preparedness Planning for US Businesses with Overseas Operations.
Information for Laboratories (CDC)
This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).
Worker Training Program (NIEHS)
The NIEHS Worker Training Program (WTP) has been tracking information about the coronavirus disease 2019 (COVID-19) as it pertains to protecting workers involved in emergency response and cleanup activities performed in the United States. This page contains health and safety resources for workers who may be at risk of exposure to COVID-19.
Guide to Conquering a Business Crisis (SBTDC)
Many business owners are wondering what they can do (outside of taking on additional debt) to help meet the challenges of COVID-19. The Guide to Conquering a Business Crisis provides suggestions for cash management, pricing and cost containment, supply chain management, and marketing.
See the SBTDC's full COVID-19 business resource guide here.
Ultimate Guide to Supply Chain Resiliency Success (Resilinc)
This document provides supply chain risk management and resiliency strategies and practices.
Best Practices for Establishing a Cross-Functional Team (NC Chamber)
This best practice document offers guidance on establishing a cross-functional team tasked with preparation, communication and incident response.
COVID-19 Control and Prevention (OSHA)
OSHA has developed this interim guidance to help prevent worker exposure to COVID-19.
Also see OSHA's 2017 Guidance on Preparing Workplaces for an Influenza Pandemic.
Advancing a Comprehensive Response to COVID-19 (Duke Margolis Center for Health Policy)
Duke-Margolis, faculty and researchers from Duke University and Duke Health System, and leaders from across the health care and health policy landscape are working together to advance collective recommendations to address the COVID-19 pandemic. The Center will be releasing new working papers, holding informational webinars, and centralizing useful resources for the policy community in the coming days and weeks.
Strategic Preparedness and Response for the new coronavirus (WHO)
This strategic preparedness and response plan outlines the public health measures that the international community stands ready to provide to support all countries to prepare for and respond to COVID-19.
Healthcare Planning Checklist (DHHS)
Planning for a potential emerging infectious disease pandemic, like COVID-19, is critical to protecting the health and welfare of our nation. This checklist identifies specific activities your jurisdiction can do now to prepare for, respond to, and be resilient in the face of COVID-19.
Families First Coronavirus Response Act: Employer Paid Leave Requirements (US Department of Labor)
The Families First Coronavirus Response Act (FFCRA or Act) requires certain employers to provide their employees with paid sick leave or expanded family and medical leave for specified reasons related to COVID-19. This page provides guidance about this new law.
Also see this Q&A with Hutchison PLLC regarding these new requirements.
Building COVID Diagnostic Capacity Now and for the Future
Host: Duke Margolis Center for Health Policy
March 31, 12:30 - 2:30 p.m.
As health researchers, policymakers, thought leaders, and community members, our responsibility lies in continuing productive dialogue around actionable solutions to the COVID-19 pandemic. The Duke-Margolis Center for Health Policy and the Alexandria Summit invite you to a webinar this Tuesday, March 31 from 12:30-2:30 pm ET that will focus on the issues, strategies, and policies for achieving widespread availability of rapid, efficient COVID-19 diagnostics. This 2-hour webinar leverages multidisciplinary expertise and cross-sector experiences to strategize the building of diagnostic capacity—for our current crisis, and the future.
Larger Than Life Science: Leading Through Uncertain Times
April 1, 4:00 - 5:00 PM
All the contingency planning in the world probably didn’t prepare you and your firm for global economic slowdown and ‘shelter in place’ orders on multiple continents. Staggered shifts are helping maintain social distance, but your workers with school-age children have no choice but to stay home. How will you keep the company’s projects moving forward and meet the challenges we all face on the other side of the coronavirus pandemic? We speak online with three life sciences CEOs about how they’re coping with the breakneck pace and scope of change we’re experiencing and then invite audience comments and questions.
COVID-19 and AI: A Virtual Conference
Host: Stanford Institute for Human-Centered Artificial Intelligence
April 1, 2020
COVID-19 and AI: A Virtual Conference will address a developing public health crisis. Sponsored by the Stanford Institute for Human-Centered Artificial Intelligence (HAI), the event will convene experts from Stanford and beyond to advance the understanding of the virus and its impact on society. It will be livestreamed to engage the broad research community, government and international organizations, and civil society.
Announcing MISSION-R: RIoT’s Moonshot Goal Response to COVID-19
April 2, 1:00 - 2:00 p.m.
The current global crisis has us fighting a two-sided war. We’re fighting for our health, in the grips of a terrible pandemic. We’re also fighting for the economy, doing what we can to support small businesses and fight waves of unemployment.
But the battle isn’t between our health and our economy—the battle is between us and the virus. And as we battle on both fronts, RIoT is brainstorming new ways for us to fight back.
In this webinar, RIoT will invite experts in the medtech and economic development space to share how they’re fighting for BOTH our health and our economy—not one or the other.
COVID-19 Unites Us All: Helpful Insights from International Digital Health Leaders
April 3, 9:00 a.m.
Join DHIT in a discussion with an international panel of digital health leaders as they discuss the challenges, strategies and transformations of care models due to COVID-19. An expert panel will consist of:
- Moderator: Michael Levy, President of DHIT (United States)
- Kathy Malas, Associate CEO – Innovation & AI for the University of Montreal Health Centre (Canada)
- Dr. Sujoy Kar, Chief Medical Information Officer & Vice President for Apollo Hospitals (India)
- Angela Yochem, EVP & Chief Digital and Technology Officer for Novant Health (United States)
Clinical Trials in the Era of COVID-19 Weekly Webinar Series
Host: WCG Clinical
Ongoing; Watch on-demand available
The continuing spread of COVID-19 has the industry’s undivided attention, as clinical trial professionals seek the latest perspective on best practices during this unprecedented time. Clinical researchers with ongoing or upcoming clinical trials are working to understand, and ameliorate the impact of this pandemic on studies to keep them on track. Join thousands of peers in these weekly online panels, designed to support healthcare researchers via the industry’s leading voices and perspectives. The panelists share expertise in real-time to inform our collective efforts to discover effective therapies, and minimize the disruption to ongoing and upcoming clinical trials.
Race for a Cure
Host: Larger Than Life Sciences
April 16, 1:00-1:45 p.m.
Amidst global concerns about the coronavirus outbreak, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. Sub-pieces of the virus are then sent to collaborators around the world who are working on formulations for a vaccine. In this fireside chat, hear from ATUM’s Co-Founder, Claes Gustafsson, on the technology behind the cure and how the biotech community is banding together for the collective good.
Local Conferences and Events
NCBiotech Exchange Group Cancellations:
- 3/30 NCBiotech Jobs Network
- 3/31 AmSci Pizza Lunch – this will now be a virtual event, details to come
- 4/1 BPD Cell and Gene Therapy Symposium & Vendor Show (postponed until fall 2020)
- 4/2 TriWiSTEM Advancing Your Career
- 4/6 PMB Seminar Series Featuring Dr. Bob Schmitz
- 4/8 SCONC Science in the Movies Event
- 4/20 PMB Seminar Series Featuring Dr. Adam Bogdanove
- 5/5 BPD Process Analytics and Automation Symposium (postponed until fall 2020)
NC Science and Engineering Fair
Raleigh, NC | March 27-28
Status: Face-to-face event cancelled; currently exploring alternative options
2020 Duke-UNC Innovation and Entrepreneurship Research Conference
Durham, NC | April 2-3
SBIR Road Tour 2020
RTP | April 15, 2020
Status: Postponed to September 14
Life Science Economic Development Summit
Durham | April 21, 2020
Status: Postponed to Spring 2021
Precision Medicine Leaders' Summit
Research Triangle Park | April 30, 2020
Status: Postponed to October 20, 2020
NC East Alliance State of the Region
Greenville, NC | May 5, 2020
Medical, Biomedical, and BioDefense: Support to the Warfighter Symposium
Chapel Hill | June 17-18
DHIT Happy Hours
Chapel Hill and Charlotte
Status: Suspended until further notice
National and International Conferences
Association of University Technology Managers (AUTM) Annual Meeting
San Diego | March 8-11
Healthcare Information Management Systems Society (HIMSS) Annual Conference
Orlando, FL | March 9-13
Toykyo | March 10-11
Animal AgTech Innovation Summit
San Francisco | March 16
World AgriTech Innovation Summit
San Francisco | March 17-18
Future Food-tech Innovation and Investment Summit
San Francisco | March 19-20
AdvanSE Life Sciences Conference
Charleston, SC | May 27-28
For the status of more life science and health care conferences, see STAT’s guide to conference disruptions.
Many journals and publishers are committing to making coronavirus and COVID-19 research articles free to access.
LitCovid from the National Library of Medicine
LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. It is the most comprehensive resource on the subject, providing a central access to 842 (and growing) peer-review articles.
North Carolina News
BioMedomics Teams with BD to Launch Rapid COVID-19 Test
Morrisville-based BioMedomics, a small diagnostics company supported by the North Carolina Biotechnology Center, has partnered with BD (Becton Dickinson & Co.) to launch its new blood test for COVID-19 that can detect the infection within 15 minutes.
Duke to Lead $50 Million Study of COVID-19 Prevention in Healthcare Workers
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine (HCQ) as a preventive drug for the novel coronavirus.
NC Startup Awaits FDA OK for ‘Low-Cost’ COVID-19 Ventilator
As the world grapples with a shortage of ventilators for COVID-19 patients, a small North Carolina life science startup has designed a low-cost option. BioMedInnovations (BMI), headquartered outside Charlotte with a research lab in Research Triangle Park, hopes to get federal fast-track approval this week to manufacture and distribute its uniquely simple device to help people breathe.
Carolina Liquid Chemistries Introduces Tests for COVID-19, Norfentanyl
Carolina Liquid Chemistries – a Greensboro diagnostics and drug screening company – has introduced two new immunoassays to test for COVID-19 and for norfentanyl, the major metabolite of the synthetic opioid pain reliever fentanyl.
Novan explores potential COVID-19 treatment, raises $8 million
A Triangle company that's struggled to develop its lead asset has brought in $8 million through a new public offering as it unveils plans to explore potential applications of its platform in the fight against COVID-19.
Article behind paywall
Q2 Solutions, U of Texas Medical Branch Team Up to Help Find COVID-19 Vaccines
Q2 Solutions, a clinical trial laboratory services organization headquartered in Morrisville, has teamed up with the University of Texas Medical Branch to develop an assay for analyzing COVID-19 vaccine candidates.
Grifols Developing Potential Treatments for COVID-19
Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, will produce and test a potential COVID-19 therapy derived from the blood plasma of patients who have recovered from the coronavirus infection.
NC's Gilero Uses Ingenuity, 3D Printing to Expand COVID-19 Protective Equipment, Ventilators
Using 3D printers, Morrisville medical device manufacturer Gilero has begun a three-tiered response to the shortage of COVID-19 protective equipment for healthcare workers.
Duke Starts Novel Decontamination of N95 Masks to Help Relieve Shortages
Facing a critical shortage of N95 face masks that block the coronavirus, Duke Health research and clinical teams have confirmed a way to use existing vaporized hydrogen peroxide methods to decontaminate the masks so they can be reused.
Duke joins first national effort to test potential COVID-19 therapy
Adults with severe symptoms of the novel illness will have the opportunity to participate in Duke University Hospital’s test of an investigational treatment with an antiviral agent known as remdesivir. Remdesivir is an antiviral agent that was previously tested in humans with Ebola virus disease and has shown promise in animal studies against MERS and SARS, diseases that emerged from different strains of the coronavirus.
Heat Biologics, University of Miami Developing Quick Point-Of-Care COVID-19 Test
Heat Biologics, a publicly traded North Carolina biotechnology company, is adding a rapid point-of-care COVID-19 diagnostic test to its product development pipeline. The new test is in addition to the provisional patent application the Morrisville company filed March 3 to apply its immune system activating technology to prevent and/or treat COVID-19.
LabCorp Able to Perform 20,000 COVID-19 Tests Per Day
LabCorp says it’s ahead of schedule in ramping up its capacity to conduct COVID-19 tests, and is now able to perform more than 20,000 of the tests per day. The Burlington-based company says it has doubled its COVID-19 testing capacity in one week at its labs in North Carolina, Arizona and New Jersey.
NCCU Awarded Grant to Help Detect Biological Threats at the Border
North Carolina Central University has received a $330,000 grant to develop tools that help the U.S. Department of Homeland Security predict and spot risks at the border from biological threats such as COVID-19, African swine fever, and insect pests.
UNC Health deploys coronavirus test
A coronavirus test developed by Melissa Miller, director of the Clinical Molecular Microbiology Laboratory at the UNC School of Medicine, was being deployed by UNC Health on Monday, officials said. The test should help reduce some of the burden on North Carolina’s public health lab regarding testing, they said.
Medicago Vaccine Could Help Smoke Out Coronavirus
An ancient relative of tobacco, much maligned for the damage it has inflicted on public health, is key to a new vaccine to prevent the novel coronavirus. Medicago – a Canadian company with a biomanufacturing facility in Durham – has used it to produce an experimental plant-based vaccine for COVID-19, the coronavirus disease that has now reached a global pandemic level.
BioMedomics Seeks FDA OK for COVID-19 Rapid Diagnostic
Morrisville-based BioMedomics, a small diagnostics company supported by the North Carolina Biotechnology Center, has developed a new test for rapidly detecting COVID-19, the coronavirus infection that is spreading rapidly throughout the world.
Biotech firm bioMerieux, which has an HQ in Durham, working on 3 coronavirus tests
France-based bioMerieux, which has a big Triangle connection, is the latest biotech firm developing tests it says will help health officials detect the coronavirus. The company, which focuses on in vitro (test tube) diagnostics, operates its headquarters for the US, Canada and Latin America in Durham.
CDC awards North Carolina $13 million to combat coronavirus
North Carolina is set to receive more than $13 million from the Centers for Disease Control and Prevention (CDC) as part of a federal initiative to combat the coronavirus pandemic.
LabCorp is performing ‘several thousands’ of coronavirus tests per day to meet surge in demand
Burlington-based life science conglomerate LabCorp says it is now performing “several thousands” of coronavirus tests per day in the wake of an increasing number of new coronavirus infections in the United States. Meanwhile, it is rapidly adding new equipment and staff to create additional capacity for patients who should be tested across the country.
NC governor declares state of emergency as state deals with coronavirus
North Carolina Gov. Roy Cooper declared a state of emergency Tuesday as leaders continue to deal with the coronavirus outbreak. The state now has 7 people who have tested positive for COVID-19, the disease caused by the coronavirus, health officials said.
For Duke researchers – 'Every virus has an Achilles' heel'
As the novel coronavirus continues to spread across the globe, researchers are racing to create a vaccine to eradicate it, including those at Duke University who have spent decades – funded by billions of dollars– studying vaccine development for some of the world's most pressing diseases.
Article behind paywall.
What We've Learned About Coronavirus: Infectious disease experts on the spread, the science and the scenarios for the virus
Three Duke infectious disease experts talked with the media Tuesday to discuss the origins and spread of COVID-19 and the global and U.S. response. Duke plans a series of briefings on the way the novel coronavirus is affecting the world.
Keep reading for highlights from the briefing.
An air-locked lab at UNC is leading research on cures for the coronavirus
For scientists working in laboratories across the world, their names usually won’t become well known outside of the subsection of people reading academic journals. But the outbreak of COVID-19 — the disease caused by the novel coronavirus that has spread from China around the globe this year — has pushed researchers at UNC-Chapel Hill, specifically Dr. Ralph Baric, into the spotlight.
RTP firm BioMedomics says it has ‘quick and easy’ coronavirus test
BioMedomics, a medical diagnostic company based in RTP, says it has developed a novel coronavirus test that can turn around results in less than 15 minutes, potentially offering a fix to the current testing backlog.
LabCorp Launches New Test for Coronavirus
Burlington-based life science conglomerate LabCorp is the latest company to provide a test for COVID-19. This coronavirus has gained a foothold in more than 84 countries so far as it continues its unrelenting march across the globe.
NC Researchers, Companies Help Lead Coronavirus Battle
The rapid global march of the coronavirus that began in Wuhan, China several months ago could be slowed by researchers and biotech firms 7,770 miles away – in the Research Triangle of North Carolina.
Morrisville-based Heat Biologics joins global effort to discover coronavirus vaccine
The Morrisville-based biotechnology company announced today that it has formally launched a program within its wholly-owned subsidiary, Zolovax, Inc., to develop a vaccine using its immune activating gp96 vaccine platform for treating or preventing infection from the SARS-CoV-2 coronavirus that causes COVID-19.